Clinical importance of Mycobacterium kansasii and evaluation of the need to identify nontuberculous mycobacteria;Significado clínico del aislamiento de Mycobacterium kansasii y valoración de la necesidad de identificación de las micobacterias no tuberculosas

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 20, Issue 3, 2002, Pages 113-116

  Etxebarrieta, Marina ^a   Rodrigo, Alberto ^a   Martín, Carmen ^a   Ojer, Montserrat ^a   Ruz, Ana ^a   Dorronsoro, Inés ^a  

^a Instituto de Investigación Sanitaria de Navarra   (Spain)

Author keywords

Diagnosis of M. kansasii; Mycobacterium kansasii; Nontuberculous mycobacteria

Indexed keywords

ADULT; AGED; ARTICLE; ATYPICAL MYCOBACTERIOSIS; ATYPICAL MYCOBACTERIUM; BACTEREMIA; BACTERIUM IDENTIFICATION; CLASSIFICATION; COMORBIDITY; EVALUATION; FEMALE; HOSPITAL LABORATORY; HOSPITAL SERVICE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; ISOLATION AND PURIFICATION; LABORATORY DIAGNOSIS; MALE; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED; NEOPLASM; RISK FACTOR; SPAIN; SPUTUM; STATISTICS;

ADULT; AGED; AGED, 80 AND OVER; BACTEREMIA; BACTERIAL TYPING TECHNIQUES; BACTERIOLOGICAL TECHNIQUES; COMORBIDITY; FALSE POSITIVE REACTIONS; FEMALE; HIV INFECTIONS; HOSPITAL SHARED SERVICES; HUMANS; IMMUNOCOMPROMISED HOST; LABORATORIES, HOSPITAL; MALE; MIDDLE AGED; MYCOBACTERIA, ATYPICAL; MYCOBACTERIUM INFECTIONS, ATYPICAL; NEOPLASMS; RISK FACTORS; SPAIN; SPUTUM;

EID: 0347998475     PISSN: 0213005X     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0213-005x(02)72760-2     Document Type: Article

References (24)

1. Griffith DE. Mycobacteria as pathogens of respiratory infection. Infect Dis Clin North Am 1998;12:593-611.
2. Kaustova J. The incidence of conditionally pathogenic mycobacteria in the northern Moravia region in 1978-1987. J Hyg Epidemiol Microbiol Immunol 1992;36:141-52.
3. Hosker HS, Lam CW, Ng TK, Ma HK, Chan SL. The prevalence and clinical significance of pulmonary infection due to non - tuberculous mycobacteria in Hong Kong. Respir Med 1995;89:3-8.
4. Wayne LG, Sramek HA. Agents of newly recognized or infrecuently encountered mycobacterial diseases. Clin Microbiol Rev 1992;5:1-25.
5. American Thoracic Society. Diagnosis and treatment of diseases caused by nontuberculous mycobacteria. Am J Respir Crit Care Med 1997;156:1-25.
6. Urkijo JC, Montejo M, Aguirrebengoa K, Urra E, Aguirre C. Disease caused by Mycobacterium kansasii in patients with HIV infection. Enferm Infecc Microbiol Clin 1993;11:120-5.
7. Lillo M, Orengo S, Cernoch P, Harris RL. Pulmonary and disseminated infection due to Mycobacterium kansasii: a decade of experience. Rev Infect Dis 1990;12:760-7.
8. Repáraz J. Enfermedad por Mycobacterium kansasii. Enferm Infecc Microbiol Clin 1999;17:85-90.
9. Dorronsoro I, Martín C, Cabodevilla B, Ojer M, Ruz A. Influencia del número de muestras estudiadas en el diagnóstico de la tuberculosis. Enferm Infecc Microbiol Clin 2000;18:215-8.
10. Kent PT, Kubica GP. Public health mycobacteriology a guide for the level III Laboratory. US Department of Health and Human Services. PB 86-216546. Atlanta: Public Health Services, 1985; p. 123.
11. Dorronsoro I, Urtasun I, Fontaneda A, García B, Elías C. Aislamiento de micobacterias oportunistas y su significado clínico. Rev Diagn Biol 1992;41: 116-8.
12. Klein JL, Corbett EL, Slade PM, Miller RF, Coker RJ. Mycobacterium kansasii and human immunodeficiency virus co-infection in London. J Infect 1998;37:252-9.
13. Corbett EL, Blumberg L, Churchyard GJ, Moloi N, Mallory K, Clayton T, et al. Nontuberculous mycobacteria: defining disease in a prospective cohort of South African miners. Am J Respir Crit Care Med 1999;160:15-21.
14. Shih JY, Hsueh PR, Lee LN, Wang HC, Yang PC, Kuo SH, et al. Nontuberculous mycobacteria isolates: clinical significance and disease spectrum. J Formos Med Assoc 1997;96:621-7.
15. Contreras MA, Cheung OT, Sanders DE, Goldstein RS. Pulmonary infection with nontuberculous mycobacteria. Am Rev Respir Dis 1998;137:149-52.
16. Shafer RW, Sierra MF. Mycobacterium xenopi, Mycobacterium fortuitum, Mycobacterium kansasii, and other nontuberculous mycobacteria in an area of endemicity for AIDS. Clin Infect Dis 1992;15:161-2.
17. Van der Meer JT, Kerssemakers SP, van Steenwijk RP, Kuijper EJ. Infections with Mycobacterium kansasii in the Academic Medical Center in Amsterdam: the changing clinical spectrum since the start of the HIV epidemic. Ned Tijdschr Geneeskd 1998;142:965-9.
18. Pintado V, Gómez Mampaso E, Martín Davila P, Cobo J, Navas E, Quereda C, et al. Mycobacterium kansasii infection in patients infected with the human immunodeficiency virus. Eur J Clin Microbiol Infect Dis 1999;18: 582-6.
19. Echevarría MP, Martín G, Pérez J, Urkijo JC. Infección pulmonar por Mycobacterium kansasii. Presentacidn de 27 casos (1988-1992). Enferm Infecc Microbiol Clin 1994;12:280-4.
20. Pang SC. Mycobacterium kansasii infections in Western Australia (1962-1987). Respir Med 1991;85:213-8.
21. Lortholary O, Deniel F, Boudon P, Le Pennec MC, Mathieu M, Soilleux M, et al. Mycobacterium kansasii infection in a Paris suburb: comparison of disease presentation and outcome according to human immunodeficiency virus status. Groupe d'Etude Des Mycobacteries de la Seine-Saint-Denis. Int J Tubec Lung Dis 1999;3:68-73.
22. Campo RE, Campo CE. Mycobacterium kansasii disease in patients infected with human immunodeficiency virus. Clin Infect Dis 1997;24:1233-8.
23. Alcaide F, Richter I, Bernasconi C, Springer B, Hagenau C, Schulze Robbecke R, et al. Heterogeneity and clonality among isolates of Mycobacterium kansasii: implications for epidemiological and pathogenicity studies. J Clin Microbiol 1997;35:1959-64.
24. Tortoli E, Simonetti MT, Lacchini C, Penati V, Urbano P. Tentative evidence of AIDS-Associated biotype of Mycobacterium kansasii. J Clin Microbiol 1994;32:1779-82.